Report Overview
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinson's Disease (PD) Drugs market size was estimated at USD 5492 million in 2023 and is projected to reach USD 8022.12 million by 2032, exhibiting a CAGR of 4.30% during the forecast period.
North America Parkinson's Disease (PD) Drugs market size was estimated at USD 1538.49 million in 2023, at a CAGR of 3.69% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Parkinson's Disease (PD) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease (PD) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease (PD) Drugs market in any manner.
Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Market Segmentation (by Type)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Market Segmentation (by Application)
Hospital
Family
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinson's Disease (PD) Drugs Market
Overview of the regional outlook of the Parkinson's Disease (PD) Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parkinson's Disease (PD) Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parkinson's Disease (PD) Drugs Market Competitive Landscape
3.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2019-2025)
3.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Parkinson's Disease (PD) Drugs Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
3.6.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinson's Disease (PD) Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parkinson's Disease (PD) Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2025)
6.3 Global Parkinson's Disease (PD) Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Parkinson's Disease (PD) Drugs Price by Type (2019-2025)
7 Parkinson's Disease (PD) Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2019-2025)
7.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2025)
8 Parkinson's Disease (PD) Drugs Market Consumption by Region
8.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease (PD) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease (PD) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Parkinson's Disease (PD) Drugs Market Production by Region
9.1 Global Production of Parkinson's Disease (PD) Drugs by Region (2019-2025)
9.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Parkinson's Disease (PD) Drugs Production
9.4.1 North America Parkinson's Disease (PD) Drugs Production Growth Rate (2019-2025)
9.4.2 North America Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Parkinson's Disease (PD) Drugs Production
9.5.1 Europe Parkinson's Disease (PD) Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Parkinson's Disease (PD) Drugs Production (2019-2025)
9.6.1 Japan Parkinson's Disease (PD) Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Parkinson's Disease (PD) Drugs Production (2019-2025)
9.7.1 China Parkinson's Disease (PD) Drugs Production Growth Rate (2019-2025)
9.7.2 China Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
10.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
10.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
10.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
10.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 Novartis
10.3.1 Novartis Parkinson's Disease (PD) Drugs Basic Information
10.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
10.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
10.3.4 Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
10.3.5 Novartis Business Overview
10.3.6 Novartis Recent Developments
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
10.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
10.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
10.4.4 Teva Pharmaceutical Industries Business Overview
10.4.5 Teva Pharmaceutical Industries Recent Developments
10.5 AbbVie
10.5.1 AbbVie Parkinson's Disease (PD) Drugs Basic Information
10.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
10.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
10.5.4 AbbVie Business Overview
10.5.5 AbbVie Recent Developments
10.6 Abital Pharma
10.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
10.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
10.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
10.6.4 Abital Pharma Business Overview
10.6.5 Abital Pharma Recent Developments
10.7 Addex Therapeutics
10.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
10.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
10.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
10.7.4 Addex Therapeutics Business Overview
10.7.5 Addex Therapeutics Recent Developments
10.8 Biogen
10.8.1 Biogen Parkinson's Disease (PD) Drugs Basic Information
10.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
10.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
10.8.4 Biogen Business Overview
10.8.5 Biogen Recent Developments
10.9 Eisai
10.9.1 Eisai Parkinson's Disease (PD) Drugs Basic Information
10.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
10.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
10.9.4 Eisai Business Overview
10.9.5 Eisai Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
10.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
10.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 F. Hoffmann-La Roche
10.11.1 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
10.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
10.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
10.11.4 F. Hoffmann-La Roche Business Overview
10.11.5 F. Hoffmann-La Roche Recent Developments
10.12 H. Lundbeck
10.12.1 H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
10.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
10.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
10.12.4 H. Lundbeck Business Overview
10.12.5 H. Lundbeck Recent Developments
10.13 Impax Laboratories
10.13.1 Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
10.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
10.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
10.13.4 Impax Laboratories Business Overview
10.13.5 Impax Laboratories Recent Developments
10.14 Kyowa Hakko Kirin
10.14.1 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
10.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
10.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
10.14.4 Kyowa Hakko Kirin Business Overview
10.14.5 Kyowa Hakko Kirin Recent Developments
10.15 Otsuka Pharmaceutical
10.15.1 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
10.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
10.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
10.15.4 Otsuka Pharmaceutical Business Overview
10.15.5 Otsuka Pharmaceutical Recent Developments
10.16 Pfizer
10.16.1 Pfizer Parkinson's Disease (PD) Drugs Basic Information
10.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
10.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
10.16.4 Pfizer Business Overview
10.16.5 Pfizer Recent Developments
11 Parkinson's Disease (PD) Drugs Market Forecast by Region
11.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast
11.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region
11.2.4 South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease (PD) Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Parkinson's Disease (PD) Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2025-2032)
12.1.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parkinson's Disease (PD) Drugs by Type (2025-2032)
12.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application
12.2.2 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
Table 10. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Parkinson's Disease (PD) Drugs Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 13. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease (PD) Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Global Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 23. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 24. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size Share by Type (2019-2025)
Table 28. Global Parkinson's Disease (PD) Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Application
Table 30. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 31. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Parkinson's Disease (PD) Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2025)
Table 35. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Parkinson's Disease (PD) Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Parkinson's Disease (PD) Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Parkinson's Disease (PD) Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Parkinson's Disease (PD) Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Parkinson's Disease (PD) Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Basic Information
Table 52. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 53. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Parkinson's Disease (PD) Drugs SWOT Analysis
Table 56. Boehringer Ingelheim Recent Developments
Table 57. GlaxoSmithKline Parkinson's Disease (PD) Drugs Basic Information
Table 58. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 59. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Parkinson's Disease (PD) Drugs SWOT Analysis
Table 62. GlaxoSmithKline Recent Developments
Table 63. Novartis Parkinson's Disease (PD) Drugs Basic Information
Table 64. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 65. Novartis Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Novartis Parkinson's Disease (PD) Drugs SWOT Analysis
Table 67. Novartis Business Overview
Table 68. Novartis Recent Developments
Table 69. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Basic Information
Table 70. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 71. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Teva Pharmaceutical Industries Business Overview
Table 73. Teva Pharmaceutical Industries Recent Developments
Table 74. AbbVie Parkinson's Disease (PD) Drugs Basic Information
Table 75. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 76. AbbVie Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. AbbVie Business Overview
Table 78. AbbVie Recent Developments
Table 79. Abital Pharma Parkinson's Disease (PD) Drugs Basic Information
Table 80. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 81. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Abital Pharma Business Overview
Table 83. Abital Pharma Recent Developments
Table 84. Addex Therapeutics Parkinson's Disease (PD) Drugs Basic Information
Table 85. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 86. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Addex Therapeutics Business Overview
Table 88. Addex Therapeutics Recent Developments
Table 89. Biogen Parkinson's Disease (PD) Drugs Basic Information
Table 90. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 91. Biogen Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Biogen Business Overview
Table 93. Biogen Recent Developments
Table 94. Eisai Parkinson's Disease (PD) Drugs Basic Information
Table 95. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 96. Eisai Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Eisai Business Overview
Table 98. Eisai Recent Developments
Table 99. Eli Lilly Parkinson's Disease (PD) Drugs Basic Information
Table 100. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 101. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Recent Developments
Table 104. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Basic Information
Table 105. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 106. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. F. Hoffmann-La Roche Business Overview
Table 108. F. Hoffmann-La Roche Recent Developments
Table 109. H. Lundbeck Parkinson's Disease (PD) Drugs Basic Information
Table 110. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 111. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. H. Lundbeck Business Overview
Table 113. H. Lundbeck Recent Developments
Table 114. Impax Laboratories Parkinson's Disease (PD) Drugs Basic Information
Table 115. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 116. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Impax Laboratories Business Overview
Table 118. Impax Laboratories Recent Developments
Table 119. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Basic Information
Table 120. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 121. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Kyowa Hakko Kirin Business Overview
Table 123. Kyowa Hakko Kirin Recent Developments
Table 124. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Basic Information
Table 125. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 126. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Otsuka Pharmaceutical Business Overview
Table 128. Otsuka Pharmaceutical Recent Developments
Table 129. Pfizer Parkinson's Disease (PD) Drugs Basic Information
Table 130. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 131. Pfizer Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Pfizer Business Overview
Table 133. Pfizer Recent Developments
Table 134. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 135. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 137. North America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 139. Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Parkinson's Disease (PD) Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 141. Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 143. South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 147. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 149. Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 150. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2019-2032
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease (PD) Drugs Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease (PD) Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Parkinson's Disease (PD) Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 24. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease (PD) Drugs Market Share by Application (2019-2025)
Figure 27. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2023
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Parkinson's Disease (PD) Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 50. South America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Parkinson's Disease (PD) Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Parkinson's Disease (PD) Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2025-2032)
